Save time and get answers to complex questions with AI chat
When will latisse patent expire?Is allopurinol expensive?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Guselkumab patent expiration?What's the recommended schedule for lurbinectedin side effect checks?
See the DrugPatentWatch profile for Auvelity
Auvelity (dextromethorphan-bupropion) contains two active pharmaceutical ingredients: dextromethorphan and bupropion. [1]
The product combines: - Dextromethorphan (an NMDA receptor antagonist) and - Bupropion (an antidepressant) as the paired active ingredients that make up Auvelity’s drug formulation. [1]
The provided information identifies Auvelity’s composition by its active ingredients (dextromethorphan and bupropion). It does not list the inactive/excipients in the formulation. [1]
You can confirm the active-ingredient composition for Auvelity using DrugPatentWatch’s listing pages. [1]
[1] DrugPatentWatch.com – Auvelity (dextromethorphan-bupropion) composition / active ingredients
Other Questions About Auvelity :